Blue Cross Blue Shield of Massachusetts reported a $400 million operating loss in 2024, driven by spending on GLP-1 medications and other rising medical costs. The nonprofit insurer reported its ...

Almost 11 million people would become uninsured if Medicaid expansion states can’t fulfill spending obligations left by potential federal Medicaid cuts, according to a Feb. 24 analysis from the Urban ...

The New Hampshire Insurance Department has issued an order requiring Aetna to prove why it should not be fined or have its operating license suspended in the state. The Feb. 26 order stems from a ...

UnitedHealthcare added more than 400,000 Medicare Advantage members during the annual open enrollment period, according to data CMS published Feb. 25. Elevance Health and UnitedHealthcare added to ...

Blue Cross Blue Shield of Michigan had more than 750,000 members across its Medicare Advantage plans in 2025, according to CMS data published Feb. 25. The Detroit-based insurer operates its own ...

In 2019, Medicare spent roughly $7.7 billion on 10 common diabetes drugs, including GLP-1 medications. By 2023, that amount reached $35.8 billion, marking a 364% increase, according to a new report ...

Centene is working to keep its youngest members out of the emergency room and set on a course for better lifelong health through a new, simple benefit: early allergen introduction. Pediatric medical ...

UnitedHealth Group's board of directors authorized a $2.10 per-share cash dividend to be paid on March 18. The dividend will be paid to all shareholders of record as of the close of business on March ...

The behavioral health crisis in America continues to escalate. With mental health conditions affecting one in five adults and contributing to over $200 billion in annual healthcare spending, ...

Few buzzwords are as popular in healthcare as "value-based care." But understanding of the term is often superficial, according to Alex Ding, MD, enterprise deputy chief medical officer at Humana. The ...

Misaligned policies, medical necessity screening tools, and incomplete clinical data are chief contributors to rising claims denial rates. They’re a challenge that costs hospitals and health systems ...